Cite

HARVARD Citation

    John, P. et al. (2022). AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363. Neuropathology & applied neurobiology. p. n/a. [Online]. 
  
Back to record